Patent details

EP1592423 Title: COMBINATION THERAPY OF ZD6474 WITH 5-FU AND/OR CPT-11

Basic Information

Publication number:
EP1592423
PCT Application Number:
PCT/GB/2004/000550
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP047100813
PCT Publication Number:
WO/2004/071397
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
COMBINATION THERAPY OF ZD6474 WITH 5-FU AND/OR CPT-11
French Title of Invention:
POLYTHERAPIE COMPRENANT DU ZD6474 AVEC DU 5-FU ET/OU DE L'OPT-11
German Title of Invention:
KOMBINATIONSTHERAPIE VON ZD6474 MIT 5-FU ODER/UND CPT-11
SPC Number:

Dates

Filing date:
11/02/2004
Grant date:
20/04/2011
EP Publication Date:
20/04/2011
PCT Publication Date:
26/08/2004
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
09/11/2005
EP B1 Publication Date:
20/04/2011
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
11/02/2014
Expiration date:
11/02/2024
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
11/02/2004
 
 

Name:
AstraZeneca AB
Address:
-, 151 85 Södertälje, Sweden (SE)

Agent

Name:
OFFICE DE BREVETS MEYERS & VAN MALDEREN
From:
21/06/2011
Address:
PO Box 111, 8002, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
RYAN Anderson Joseph, c/o Astrazeneca R & D
Address:
United Kingdom (GB)

2

Name:
WEDGE Stephen Robert, c/o AstraZeneca R & D
Address:
United Kingdom (GB)

Priority

1

Priority Number:
0303289
Priority Date:
13/02/2003
Priority Country:
United Kingdom (GB)

2

Priority Number:
0314100
Priority Date:
18/06/2003
Priority Country:
United Kingdom (GB)

3

Priority Number:
0316184
Priority Date:
10/07/2003
Priority Country:
United Kingdom (GB)

4

Priority Number:
0318311
Priority Date:
05/08/2003
Priority Country:
United Kingdom (GB)

Classification

Main IPC Class:
A61K 31/4745;
Filing date Document type Number of pages